Global Vaccines Market to reach US$ 60 Billion by the year 2022. Pediatric vaccines market is having a dominant market share compared to Adult vaccines market, Report Buyers research said. According to the report, yy 2022 Pediatric vaccines market share will be double the size of adult vaccines market share.

Worldwide the number of infants immunized by influenza vaccines remain considerably low than that of adults immunized in year 2017. While the number of Rotavirus doses administered in infants is forecast to increase over the years and reach nearly 15 Million by the year 2022.

Adult Vaccine Market Share Analysis

Out of the total 9 Adult vaccines (Influenza, Cervical Cancer, Zoster, MMRV, Pneumococcal, Meningococcal, Hepatitis, TdaP, Travel) studied in the report Influenza vaccines dominates the adult vaccine market in 2017.

Pediatric Vaccine Market Share Analysis

Report Buyer’s analysis found that in year 2017; Pneumococcal and Combination vaccine together accounts for nearly 50% of the pediatric vaccine market share. Other Pediatric vaccines market studied in the report are as follows: Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Combos, Polio, Rotavirus, Varicella.

In 2017 Combos Vaccines will control the Immunization Share

For the year 2017; Combos (Combination Vaccines) has the maximum immunization share among all pediatric vaccines (Influenza, MMR, Pneumococcal, Meningococcal, Hepatitis, DTap, Haemophilus Influenzae Type b(Hib), Polio, Rotavirus, Varicella) studied in the report as they protect against more ailments in single shot, people preferring to get combination vaccine instead of a specific vaccine.